To better understand the potential molecular mechanisms of the MAP3K14 in the progression and survival of HCC, MAP3K14 mRNA expression levels were evaluated in 371 primary tumor tissues and 50 normal tissue samples from the UALCAN database. This evidence concerns the gene MAP3K14 and hepatocellular carcinoma.